Abstract
In this study, we investigated the effects of various histone deacetylase (HDAC) inhibitors on adipocyte differentiation. Treatment of 3T3-L1 cells with HDAC inhibitors such as apicidin, trichostatin A, or suberoylanilide hydroxamic acid, under conditions that normally promote differentiation led to a dramatic attenuation of adipocyte differentiation. In contrast, sodium butyrate (NaB) treatment increased adipocyte differentiation. Accordingly, the expression of adipogenic marker genes such as FAS, aP2, PPARγ, resistin, C/EBPα, ADD1/SREBP1c, and adiponectin were inhibited by apicidin treatment but not NaB, indicating that the adipocyte differentiation process could be differentially regulated depending on the type of HDAC inhibitor utilized. In addition, this differential effect seemed not to be due to disruption of the insulin- signaling pathway. Interestingly, our data showed that apicidin treatment could induce dedifferentiation of fully differentiated adipocytes, as evident by the fact that apicidin treatment led to a decrease of Oil Red O-stained adipocytes with a concomitant reduction in the expression levels of adipogenic marker genes. Collectively, our results suggest that adipocyte differentiation and dedifferentiation may be regulated by HDAC inhibitors.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bays, H., Mandarino, L., and Defronzo, R. A., Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferatoractivated receptor agonists provide a rational therapeutic approach. J Clin Endocrinol Metab, 89, 463–478 (2004).
Berger, S. L., Histone modifications in transcriptional regulation. Curr Opin Genet Dev, 12, 142–148 (2002).
Cho, K. J., Moon, H. E., Moini, H., Packer, L., Yoon, D. Y., and Chung, A. S., Alpha-lipoic acid inhibits adipocyte differentiation by regulating pro-adipogenic transcription factors via mitogen-activated protein kinase pathways. J Biol Chem, 278, 34823–34833 (2003).
Farmer, S. R., Transcriptional control of adipocyte formation. Cell Metab, 4, 263–273 (2006).
Gray, S. G. and Teh, B. T., Histone acetylation/deacetylation and cancer: an “open” and “shut” case? Curr Mol Med, 1, 401–429 (2001).
Gregory, P. D., Wagner, K., and Horz, W., Histone acetylation and chromatin remodeling. Exp Cell Res, 265, 195–202 (2001).
Han, J. W., Ahn, S. H., Kim, Y. K., Bae, G. U., Yoon, J. W., Hong, S., Lee, H. Y., Lee, Y. W., and Lee, H. W., Activation of p21(WAF1/Cip1) transcription through Sp1 sites by histone deacetylase inhibitor apicidin: involvement of protein kinase C. J Biol Chem, 276, 42084–42090 (2001).
Haruta, T., Uno, T., Kawahara, J., Takano, A., Egawa, K., Sharma, P. M., Olefsky, J. M., and Kobayashi, M., A rapamycin-sensitive pathway down-regulates insulin signaling via phosphorylation and proteasomal degradation of insulin receptor substrate-1. Mol Endocrinol, 14, 783–794 (2000).
Hou, M., Wang, X., Popov, N., Zhang, A., Zhao, X., Zhou, R., Zetterberg, A., Bjorkholm, M., Henriksson, M., Gruber, A., and Xu, D., The histone deacetylase inhibitor trichostatin A derepresses the telomerase reverse transcriptase (hTERT) gene in human cells. Exp Cell Res, 274, 25–34 (2002).
Kadam, S., and Emerson, B. M., Mechanisms of chromatin assembly and transcription. Curr Opin Cell Biol, 14, 262–268 (2002).
Kim, S., Kang, J. K., Kim, Y. K., Seo, D. W., Ahn, S. H., Lee, J. C., Lee, C. H., You, J. S., Cho, E. J., Lee, H. W., and Han, J. W., Histone deacetylase inhibitor apicidin induces cyclin E expression through Sp1 sites. Biochem Biophys Res Commun, 342, 1168–1173 (2006).
Kim, Y. K., Choi, H. Y., Kim, N. H., Lee, W., Seo, D. W., Kang, D. W., Lee, H. Y., Han, J. W., Park, S. W., and Kim, S. N., Reversine stimulates adipocyte differentiation and downregulates Akt and p70(s6k) signaling pathways in 3T3-L1 cells. Biochem Biophys Res Commun, 358, 553–538 (2007).
Kim, Y. K., Han, J. W., Woo, Y. N., Chun, J. K., Yoo, J. Y., Cho, E. J., Hong, S., Lee, H. Y., Lee, Y. W., and Lee, H. W., Expression of p21(WAF1/Cip1) through Sp1 sites by histone deacetylase inhibitor apicidin requires PI 3- kinase-PKC epsilon signaling pathway. Oncogene, 22, 6023–6031 (2003).
Kohn, A. D., Summers, S. A., Birnbaum, M. J., and Roth, R. A., Expression of a constitutively active Akt Ser/Thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation. J Biol Chem, 271, 31372–31378 (1996).
Rosen, E. D., Walkey, C. J., Puigserver, P., and Spiegelman, B. M., Transcriptional regulation of adipogenesis. Genes Dev, 14, 1293–1307 (2000).
Sakaue, H., Ogawa, W., Matsumoto, M., Kuroda, S., Takata, M., Sugimoto, T., Spiegelman, B. M., and Kasuga, M., Posttranscriptional control of adipocyte differentiation through activation of phosphoinositide 3-kinase. J Biol Chem, 273, 28945–28952 (1998).
Smas, C. M. and Sul, H. S., Pref-1, a protein containing EGF-like repeats, inhibits adipocyte differentiation. Cell, 73, 725–734 (1993).
Soukas, A., Socci, N. D., Saatkamp, B. D., Novelli, S., and Friedman, J. M., Distinct transcriptional profiles of adipogenesis in vivo and in vitro. J Biol Chem, 276, 34167–34174 (2001).
Spiegelman, B. M., PPAR-gamma: adipogenic regulator and thiazolidinedione receptor. Diabetes, 47, 507–514 (1998).
Strahl, B. D. and Allis, C. D., The language of covalent histone modifications. Nature, 403, 41–45 (2000).
Takano, A., Usui, I., Haruta, T., Kawahara, J., Uno, T., Iwata, M., and Kobayashi, M., Mammalian target of rapamycin pathway regulates insulin signaling via subcellular redistribution of insulin receptor substrate 1 and integrates nutritional signals and metabolic signals of insulin. Mol Cell Biol, 21, 5050–5062 (2001).
Tong, Q., Dalgin, G., Xu, H., Ting, C. N., Leiden, J. M., and Hotamisligil, G. S., Function of GATA transcription factors in preadipocyte-adipocyte transition. Science, 290, 134–138 (2000).
Um, S. H., Frigerio, F., Watanabe, M., Picard, F., Joaquin, M., Sticker, M., Fumagalli, S., Allegrini, P. R., Kozma, S. C., Auwerx, J., and Thomas, G., Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. Nature, 431, 200–205 (2004).
Yoo, E. J., Chung, J. J., Choe, S. S., Kim, K. H., and Kim, J. B., Down-regulation of histone deacetylases stimulates adipocyte differentiation. J Biol Chem, 281, 6608–6615 (2006).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kim, SN., Choi, HY. & Kim, Y.K. Regulation of adipocyte differentiation by histone deacetylase inhibitors. Arch. Pharm. Res. 32, 535–541 (2009). https://doi.org/10.1007/s12272-009-1409-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-009-1409-5